LLS response to Senator Charles E. Grassley letters of inquiry regarding public disclosure of industry support dated December 7, 2009 and May 4, 2011
The Leukemia & Lymphoma Society (LLS) is committed to maintaining the highest standards of compliance and transparency regarding the support we receive from Industry and Allied Health partners. LLS does receive financial support from the pharmaceutical and the Allied Health Industry. Accordingly, we identify these donations in our Annual Report, which is published annually. The LLS Annual Report is distributed to LLS individual, corporate and foundation donors. The Annual report is also available as a PDF document on the LLS website, as are all LLS educational programs and printed materials.
LLS accepts funding from corporate donors, including pharmaceutical, medical device and insurance industries when it identifies companies that will provide support for LLS programs, research or fundraising/campaign events. LLS applies for industry funding through grant requests to individual companies. LLS will only accept industry funding that is free of influence as to the content, format or delivery of its educational, research, public policy and fundraising programs. This policy is directed by the National Office of LLS and is followed by all LLS chapter offices as well.